|
Age (per 5 year increase)
|
244
|
1.105
|
0.999
|
1.222
|
.052
|
|
Male vs Female
|
245
|
1.475
|
0.963
|
2.258
|
.07
|
|
Referred to KATH: Yes vs No
|
189
|
0.828
|
0.514
|
1.333
|
.44
|
|
Reason for Admission (Yes vs No)
|
|
Constitutional symptoms
|
240
|
0.832
|
0.512
|
1.353
|
.46
|
|
Neurological symptoms
|
239
|
2.113
|
1.362
|
3.279
|
.001
|
|
Pulmonary symptoms
|
240
|
0.892
|
0.566
|
1.407
|
.62
|
|
Cardiac symptoms
|
240
|
0.871
|
0.433
|
1.753
|
.70
|
|
Gastrointestinal symptoms
|
241
|
0.538
|
0.301
|
0.962
|
.04
|
|
Other reason for admission
|
243
|
1.576
|
0.783
|
3.171
|
.20
|
|
Months since HIV diagnosis (per 1 month increase)
|
205
|
1.004
|
0.998
|
1.009
|
.18
|
|
New vs Known HIV diagnosis
|
244
|
0.866
|
0.554
|
1.353
|
.53
|
|
HAART: Yes vs No
|
237
|
0.969
|
0.625
|
1.502
|
.89
|
|
Prophylaxis Medication: Yes vs No
|
235
|
1.146
|
0.675
|
1.945
|
.61
|
|
HgB (per 1 unit increase)
|
230
|
0.996
|
0.964
|
1.029
|
.81
|
|
PLT (per 5 unit increase)
|
224
|
1.003
|
0.996
|
1.010
|
.43
|
|
Febrile Exam: Yes vs No
|
232
|
1.342
|
0.845
|
2.132
|
.21
|
|
Clinical Stage (vs Stage 0–2)
|
244
| | | |
.12
|
|
Stage 3
| |
2.937
|
0.707
|
12.191
|
.14
|
|
Stage 4
| |
3.794
|
0.918
|
15.680
|
.07
|
|
Final Diagnoses (Yes vs No)
|
|
ICSOL
|
245
|
1.724
|
1.084
|
2.742
|
.02
|
|
ICSOL with CT
|
56
|
0.402
|
0.162
|
1.000
|
.0501
|
|
CT-suggestive Toxoplasmosis
|
245
|
0.553
|
0.174
|
1.756
|
.32
|
|
Pulmonary TB
|
245
|
1.041
|
0.670
|
1.619
|
.86
|
|
Encephalopathy
|
244
|
2.133
|
0.927
|
4.909
|
.07
|
|
Pneumonia
|
245
|
1.787
|
1.089
|
2.931
|
.02
|
|
Gastroenteritis
|
245
|
1.217
|
0.586
|
2.527
|
.60
|
|
Candidiasis
|
245
|
0.939
|
0.536
|
1.643
|
.82
|
|
Pleural Effusion
|
245
|
0.735
|
0.317
|
1.701
|
.47
|
|
HTN
|
245
|
0.610
|
0.246
|
1.511
|
.29
|
|
Anemia
|
245
|
1.139
|
0.744
|
1.743
|
.55
|
|
HIV-Associated nephropathy
|
245
|
1.331
|
0.487
|
3.640
|
.58
|
|
Hepatitis B
|
245
|
1.175
|
0.511
|
2.702
|
.70
|
|
Diarrhea
|
245
|
1.001
|
0.404
|
2.478
|
.99
|
